Results 191 to 200 of about 11,186,117 (295)

Flora et Vegetatio Sudano-Sambesica : Volume 14 - 2011 [PDF]

, 2011
Wittig, Rüdiger
core  

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Evaluating evidence-based recruitment strategies for Alzheimer's disease and related dementias clinical trial research: A literature review. [PDF]

J Prev Alzheimers Dis
Jacobson M, Deuschle C, Peneva D, Wang AN, Roache C, Walsh M, Ferrell PB, Manetas MA, Raman R, Aisen P, Goldman D.   +10 more
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

What's a "Cognitive" Intervention? The PICC-M Framework to Distinguish Cognitive Remediation, Stimulation, Training, Therapy, and Rehabilitation. [PDF]

Can Geriatr J
Pishdadian S, Jin J.
europepmc   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Bridging theory and practice in model-informed precision dosing of medication in inflammatory skin diseases. [PDF]

J Eur Acad Dermatol Venereol
van den Reek JMPA, de Jong EMGJ.
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Coping with racism: Qualitative profiles of adolescents' responses to racial-ethnic discrimination. [PDF]

J Res Adolesc
Salcido VV, Lobo FM, Wang H, Coulter K, Livas G.   +4 more
europepmc   +1 more source

Réunion du comité de pilotage du réseau régional de santé animale CaribVET et atelier influenza aviaire, Trinité et Tobago, avril 2006 [PDF]

, 2006
CIRAD-EMVT - FRA
core